Can a blood test predict your risk of dying from metabolic disease?

NCT ID NCT04194372

Recruiting now Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting blood samples and health data from 10,000 hospitalized patients with metabolic diseases like diabetes, obesity, or metabolic syndrome. Researchers will analyze genetic and other markers to create a personalized risk profile for death. The goal is to improve prediction of mortality in this group, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to predict which patients with metabolic diseases are at highest risk of death, helping doctors personalize care.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve health, and the risk profile may not be accurate for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METABOLIC DISEASE

Contacts and locations

Locations

Ch Boulogne-Sur-Mer
RECRUITING

Boulogne-sur-Mer, 59037, France
Hop Cardiologique Chr Lille
RECRUITING

Lille, 59037, France
Hop Claude Huriez Chr Lille
RECRUITING

Lille, 59037, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.